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ABSTRACT
A 2-year prospective study was performed of children with prolonged coughing to investigate the
frequency of different respiratory pathogens, the rate of mixed infections, and possible differences in
severity of disease between single and mixed infections. Sera from 135 children (136 episodes of
prolonged coughing lasting 1–6 weeks) were tested for antibodies to different viruses and bacteria.
Swabs were taken for culture and PCR to detect different viral and bacterial pathogens. One or more
pathogens were found in 91 (67%) patients. One infectious agent was found in 49 (36%) patients, two
agents in 35 (26%) patients, and more than two agents in seven (5%) patients. The most frequent
pathogens encountered were rhinovirus (n = 43; 32%), Bordetella pertussis (n = 23; 17%) and respiratory
syncytial virus (n = 15; 11%). The most frequent mixed infection was B. pertussis and rhinovirus (n = 14;
10%). No signiﬁcant differences in clinical symptoms were observed between patients with or without
pathogens; however, patients with mixed infections were signiﬁcantly older. There was a strong
seasonal inﬂuence on the number of infections, but not on the number of mixed infections. In children
with prolonged coughing, there was a high frequency of mixed infections regardless of the season.
However, mixed infection was not associated with increased disease severity. No clinical symptoms
were found that allowed discrimination between speciﬁc pathogens.
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INTRODUCTION
Prolonged coughing is a frequent symptom in
children and is often associated with respiratory
tract infection [1]. Although prolonged coughing
is a prominent feature of infection with Bordetella
pertussis, infections with other respiratory tract
pathogens may also cause prolonged coughing
[2]. Mixed infections with a combination of two or
more pathogens occur, but data on clinical
manifestations of combined infections derived
from retrospective studies are often difﬁcult to
interpret [2–5]; nevertheless, it has been suggested
that mixed infections may result in more severe
illness, especially in younger children [3,4,6]. In
an earlier retrospective observational study
(unpublished data) involving 81 children with
serologically proven B. pertussis infection, evi-
dence was found in 28% of the children for
concomitant infections with other respiratory
tract pathogens. It is known that many such
pathogens may cause prolonged coughing in
children, but prolonged coughing is not always
caused by a respiratory tract infection [1,7,8]. The
present study investigated the role of different
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respiratory pathogens in prolonged coughing in
children, as well as the frequency of occurrence of
possible mixed infections. In addition, the sever-
ity of disease in patients with one or more
pathogens was compared with that in patients
for whom no pathogens were detected.
MATERIALS AND METHODS
Patients
Participating patients (aged £ 18 years) were those referred
with persistent coughing to the outpatient clinic of the
Department of Pediatrics at Groene Hart hospital, a 500-bed
general hospital in Gouda, The Netherlands, between Septem-
ber 2001 and September 2003. Disease duration was deﬁned as
the time between onset of symptoms and ﬁrst visit to the
hospital. The deﬁnition of prolonged, chronic or persistent
cough has varied from 5 days to > 1 month [2,7,9–12]. Patient
selection in the present study was based on a persistent cough
lasting 1–6 weeks. Patients with aspiration of a foreign body or
patients known to have cystic ﬁbrosis were excluded. Blood
samples were analysed at the ﬁrst visit for erythrocyte
sedimentation rate, C-reactive protein level, leukocyte count
and differentiation, and serological evidence of respiratory
pathogens (see below). Oropharyngeal, nasal and nasopha-
ryngeal swabs were taken for culture and PCR analysis for
respiratory pathogens (see below). When the disease duration
on the ﬁrst visit was < 14 days, serological tests were repeated
after 2 weeks, except for B. pertussis. When serology and PCR
results at the ﬁrst visit were negative for B. pertussis, the
serological testing was repeated 4 weeks later (after 6 weeks
for children aged < 1 year). The patients, or their parents, were
asked to complete a questionnaire regarding symptoms,
previous diseases and vaccination status. All gave their written
informed consent to participate in the study. A follow-up
telephone interview was conducted c. 4 weeks after enrolment.
The study was approved by the Medical Ethics Committee of
the hospital. A healthy control group was not included in this
study.
Serology
Positive serology for B. pertussis was deﬁned as at least a four-
fold increase in IgG to pertussis toxin (IgG-PT) in paired sera
to a level of ‡ 20 U ⁄mL, or a high IgG-PT concentration in a
single serum, i.e., > 100 U ⁄mL, as measured by the in-house
IgG-PT ELISA of the National Institute of Public Health and
the Environment (RIVM), Bilthoven, The Netherlands [13]. The
interpretation criteria of the IgG-PT ELISA have been shown to
have a sensitivity and speciﬁcity of 90% and 97%, respectively
[14].
All sera were tested for antibodies to respiratory syncytial
virus (RSV), inﬂuenza viruses A and B, adenovirus, parain-
ﬂuenza viruses 1, 2 and 3, Mycoplasma pneumoniae, Chlamydia
spp. and Coxiella burnetii by the Regionaal Medisch Micro-
biologisch Laboratorium (Rotterdam, The Netherlands) with
the complement ﬁxation method (Serion Immunodiagnostica,
Wu¨rzburg, Germany). Two-point serology against these path-
ogens was considered proof of a recent infection when there
was a four-fold or more increase or decrease in titre. In
one-point serology, a titre ‡ 128 was considered to indicate
recent infection, while a titre ‡ 64 was considered to be
equivocal, except for C. burnetii (‡ 4 equivocal) and Chlamydia
(‡ 8 equivocal) [15]. An indirect IgM immunoﬂuorescence
assay (Serion Immunodiagnostica) was performed when the
complement ﬁxation method was equivocal. A positive IgM
result, together with an equivocal complement ﬁxation test
result, was also considered to be proof of a recent infection. As
there are serological cross-reactions between parainﬂuenza
virus types 1, 2 and 3, these results were reported together.
PCR
Detection of B. pertussis and Bordetella parapertussis was by
PCR, using a MagNa Pure LC Total Nucleic Acid Isolation Kit
(Roche Diagnostics, Indianapolis, IN, USA) and primer pairs
based on IS481 and IS1001. The ﬁnal PCR product was
analysed by gel electrophoresis and by dot-blot hybridisation
[16,17].
PCRs for Chlamydia pneumoniae, M. pneumoniae, inﬂuenza
viruses A and B, coronaviruses 229E and OC43, RSV, human
metapneumovirus, rhinovirus and enterovirus were performed
on a nasal and a throat swab.A negative control (virus transport
medium) was included for every four clinical samples. A
positive control containing each pathogenwas included in each
DNAandRNAextraction and PCR run. DNAwas isolatedwith
a proteinase K and sodium dodecyl sulphate extraction, essen-
tially as described previously [18]. RNA was isolated with a
High Pure RNA isolation kit (Roche), with the addition of
poly(A) RNA as carrier, according to the manufacturer’s
instructions. An aliquot of the isolated DNA was used in a
PCRdetecting eitherM.pneumoniae [18] orChlamydia pneumoniae
[19]. An aliquot of the eluted RNA preparation was used for the
detection of rhino ⁄ enterovirus [20], inﬂuenza virusesA [21] and
B [22], and human metapneumovirus [23] in separate single-
tube RT-PCRs. RSV [24] and coronaviruses OC43 and 229E [25]
were ampliﬁed in a multiplex single-tube nested RT-PCR.
Culture for respiratory bacterial pathogens
An oropharyngeal swab was inoculated on to a blood agar
plate, a blood agar plate containing oxolinic acid (10 mg ⁄L),
and a chocolate agar plate. b-Haemolytic group A streptococci,
Haemophilus inﬂuenzae, Streptococcus pneumoniae and Moraxella
catarrhalis were considered to be potential pathogens. Staphy-
lococcus aureus, Neisseria meningitidis, non-group A b-haemo-
lytic streptococci and Candida albicans were also reported, but
were not considered to be pathogens. Only cultures showing
signiﬁcant growth were considered to be positive [26]. Non-
pathogenic oropharyngeal ﬂora (e.g., viridans streptococci,
diptheroids, coagulase-negative staphylococci) were not
reported.
Statistical analysis
For the description of patient characteristics, median and
interquartile ranges were calculated. A statistical comparison
was made between three groups of children, i.e., children in
whom no pathogen was detected, children with only one
pathogen, and children with two or more pathogens. The chi-
square test or, for continuous variables, analysis of variance
(ANOVA) was used.
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RESULTS
During the 2-year period, 152 patients were
referred for prolonged coughing, of whom 11
refused to participate in the study. Five patients
were not included because of protocol violation.
The remaining 136 episodes related to 135
patients, since one patient had two episodes of
coughing with an interval of 5.2 months, which
were considered as two independent events.
Patient characteristics are summarised in Table 1.
One or more pathogens were found in 91 (67%)
patients. Of these patients, 49 (36%) had one
pathogen, 35 (26%) had two pathogens, six (4%)
patients had three pathogens, and one (1%) had
four pathogens. The presence of more than one
pathogen in patients was detected throughout the
entire year of the study in children of all ages. The
different pathogens detected are listed in Table 2.
All respiratory pathogens found in the present
study were considered to be possible causes of
prolonged coughing, even though patients may
also be colonised by some of the pathogens found.
The pathogens detected most frequently were
rhinovirus (43 patients; 47%), B. pertussis
(23 patients; 25%) and RSV (15 patients; 16%)
(Table 2). In the 42 patients with a mixed infection
(Table 3), the most frequent combination was
B. pertussis and rhinovirus (n = 14).
Fifteen of the 27 positive bacterial cultures were
found in patients with more than one pathogen
(Table 3). There were 11 patients with a positive
oropharyngeal culture and one other pathogen. In
only one of these patients (with a C-reactive
protein level of 109 mg ⁄L) was the bacterial
infection considered to inﬂuence the course of
the disease, while the other ten patients showed
no clinical sign of a bacterial infection. It was
difﬁcult to assess whether the results for these ten
patients represented a mixed or a consecutive
infection, or whether the bacteria found simply
reﬂected carriage. Therefore, these cases were not
considered to be possible mixed infections. On the
basis of serology, PCR and culture, 21 (24%) of
the remaining 32 patients with more than one
pathogen detected were considered to have a
possible mixed infection (14 of these had a
positive PCR for two or three pathogens), nine
had a consecutive infection, and two had both.
There were no signiﬁcant differences between
patients with or without pathogens with respect to
disease duration before presentation, disease
severity (antibiotics, hospitalisation, length of stay,
coughing and other symptoms, such as headache,
sore throat or pain) or vaccination status (Tables 1
and 4). However, children with more than one
pathogen were, on average, 3 years older than
children with one or no pathogens (Table 1;
p 0.005). Although there were no signiﬁcant dif-
ferences in coughing during different parts of the
day, there seemed to be a tendency for children
with more than one pathogen to cough more
frequently (Table 4). There were no signiﬁcant
differences in coughing or other symptoms for the
three pathogens foundmost frequently, except that
patientswith B. pertussis had less fever. All patients
recovered, although the time to recovery was not
recorded accurately. Data regarding coughing in
the family or other potential contaminators were
not recorded.
DISCUSSION
To our knowledge, this is the ﬁrst study in which
a broad spectrum of respiratory pathogens has
been studied prospectively in children selected by
persistent coughing. As found in the present
study, rhinovirus is associated frequently with
respiratory disease in children of all ages [27–30],
with incidences ranging from 21% to 40% in
Table 1. Clinical data for all patients, grouped according to the number of potential pathogens isolated
All patients
No pathogen
detected
One pathogen
detected
More than one
pathogen detected p value
n 136 45 (33%) 49 (36%) 42 (31%)
Age, years (median and interquartile range) 2.7 (0.6–6.4) 1.3 (0.6–5.8) 1.0 (0.4–5.0) 4.4 (1.8–9.0) 0.005
Male gender 80 (59%) 27 (60%) 31 (63%) 22 (52%) 0.56
Disease duration, days (median and interquartile range)a 14 (10–20) 15 (13–21) 14 (9–17) 14 (9–20) 0.33
Vaccination statusb 124 (92%) 41 (91%) 44 (90%) 39 (95%) 0.64
Admission to hospital 51 (38%) 16 (36%) 22 (45%) 13 (31%) 0.37
Length of stay following admission, days (median and interquartile range) 5 (3–7) 3.5 (2–6) 5 (3–7) 5 (4–7) 0.49
Antibiotics prescribed 68 (50%) 22 (49%) 23 (47%) 23 (55%) 0.75
aDisease duration: time between ﬁrst day of illness and ﬁrst presentation in the hospital.
bInformation on vaccination status (regular vaccinations appropriate for age) was missing for one patient.
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children with overt infection, but with an inci-
dence of 20% in one study of children without
nasal symptoms [29]. Rhinovirus can cause mild
upper airway disease, and can also play a role in
more severe respiratory tract infection. It is
difﬁcult to compare the results regarding the
frequency of various pathogens obtained in the
present study with those of other studies on
respiratory tract infections among children, since
such studies have been mainly retrospective
[2,4–6,8–10,30–44]. The incidence of pathogenic
agents responsible for respiratory infection in the
present study was 67%, which is comparable with
the results of some studies (incidences of 56–64%)
[2,9,33,40], but different from those of others
(incidences of 80–90%) [9,30,37].
A relatively high incidence (10% of all patients)
of co-infection with rhinovirus and B. pertussis
Table 2. Respiratory pathogens de-
tected in the study and means of
detection
Children with
pathogen n = 91
(67%)a
Diagnostic test
Serology PCR Both Culture
Pathogens
Bordetella pertussis 23 (25%) 3 8 12 ND
Bordetella parapertussis 1 (1%) ND 1 ND ND
Inﬂuenza virus A or B 5 (5%) 5 0 0 ND
Adenovirus 6 (7%) 6 ND ND ND
Mycoplasma pneumoniae 6 (7%) 4 1 1 ND
Parainﬂuenza virus 9 (10%) 9 ND ND ND
Respiratory syncytial virus 15 (16%) 14 1 0 ND
Rhinovirus 43 (47%) ND 43 ND ND
Human metapneumovirus 1 (1%) ND 1 ND ND
Enterovirus 4 (4%) ND 4 ND ND
Chlamydia pneumoniae 1 (1%) 0 0 1 ND
Carriage organisms
Streptococcus pneumoniae 1 (1%) ND ND ND 1
Haemophilus parainﬂuenzae 7 (8%) ND ND ND 7
Staphylococcus aureus 1 (1%) ND ND ND 1
Haemophilus inﬂuenzae non-type b 12 (13%) ND ND ND 12
Haemophilus inﬂuenzae type b 1 (1%) ND ND ND 1
b-Haemolytic streptococci group C 1 (1%) ND ND ND 1
b-Haemolytic streptococci group G 1 (1%) ND ND ND 1
b-Haemolytic streptococci group B 1 (1%) ND ND ND 1
Candida albicans 2 (2%) ND ND ND 2
Total 141
aTwo or more pathogens were found in 42 patients.
Table 3. Combinations of respiratory pathogens detected in 42 patients with more than one pathogen
Bordetella
pertussis
Bordetella
parapertussis
Inﬂuenza
virus A or B Adenovirus
Mycoplasma
pneumoniae
Parainﬂuenza
virus
Respiratory
syncytial virus Rhinovirus
Pathogens
Bordetella pertussis
Bordetella parapertussis
Inﬂuenza virus A or B
Adenovirus 2a 1b 1
Mycoplasma pneumoniae
Parainﬂuenza virus
Respiratory syncytial virus 1 1 1
Rhinovirus 14c 2 2d 2a
Human metapneumovirus
Enterovirus 1 1 1
Chlamydia pneumoniae
Carriage organisms
Streptococcus pneumoniae 1
Haemophilus parainﬂuenzae 1 1
Staphylococcus aureus
Haemophilus inﬂuenzae non-type b 1 3 1
Haemophilus inﬂuenzae type b 1
b-Haemolytic streptococci group C
b-Haemolytic streptococci group G 1e
b-Haemolytic streptococci group B 1c
Candida albicans 1
Three pathogens were detected in six patients, and four pathogens in one patient.
aOne patient also had Haemophilus parainﬂuenzae.
bAlso respiratory syncytial virus.
cOne patient also had Mycoplasma pneumoniae.
dOne patient also had respiratory syncytial virus and Haemophilus parainﬂuenzae.
eOne patient also had Haemophilus inﬂuenzae non-type b.
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was observed. Among children infected with
B. pertussis, co-infection with rhinovirus was
found in 61% of cases. The role of B. pertussis in
rhinovirus infection is complicated; indeed it has
been reported that rhinovirus-induced changes in
airway smooth muscle responsiveness in isolated
rabbit and human airway smooth muscle tissue,
as well as cultured airway smooth muscle cells,
were largely prevented by pretreating the tissues
with pertussis toxin or with a monoclonal block-
ing antibody to intercellular adhesion molecule-1,
the principal endogenous receptor for most rhino-
viruses [45]. This might indicate that co-infection
with rhinovirus and B. pertussis is not as severe as
might be expected. This hypothesis was suppor-
ted by the observation in the present study that
coughing and other clinical symptoms did not
differ signiﬁcantly from those in patients infected
with either rhinovirus or B. pertussis, and the fact
that, although there was a co-infection incidence
of 61% with B. pertussis and rhinovirus, there was
less fever in the co-infected group, as would be
expected with B. pertussis infection alone. In
agreement with other studies [2,9,31,44,46], no
pathogens or positive serological results were
obtained for 33% of the patients in the present
study, although pathogens as yet unidentiﬁed
may be associated with prolonged coughing in
this group, as exempliﬁed by the recent descrip-
tion of human metapneumovirus and human
coronavirus NL63 [23,47,48].
Asymptomatic children were not recruited as a
control group, since this was considered to be too
distressing for children. However, the occurrence
of pathogens in subjects without coughing would
provide data on the incidence of carriage of
potential pathogens without disease. Some studies
have observed fewer viruses in non-symptomatic
controls compared with patients [32–35].
Gunnarsson et al. [31] isolated S. pneumoniae,
H. inﬂuenzae and Moraxella catarrhalis more
frequently from patients with long-standing
cough than from healthy individuals of the same
age. In a case-control study involving general
practitioner patients of all ages with acute respir-
atory tract infections, signiﬁcantly fewer viruses
were detected in controls than in patients (19% vs.
54%) [36].
Most patients with a positive culture for patho-
genic bacteria will not have a bacterial respiratory
tract infection. Since carriage rates for potential
pathogenic bacteria in healthy young children
may vary between 11% and 48% [31,49], it is
difﬁcult to establish whether these bacteria may
have a clinical inﬂuence. In a logistic regression
analysis, although not statistically signiﬁcant,
there was a greater association with coughing in
the morning for pathogens diagnosed by PCR or
serology than for pathogens diagnosed by oro-
pharyngeal bacterial culture (OR, 2.0 vs. 0.8).
Similar associations were found when coughing
patterns at other times of the day were analysed.
Therefore, it can be argued that a positive bacter-
ial oropharyngeal culture is of little value in the
search for respiratory pathogens causing pro-
longed cough.
More than one pathogen was detected in 31% of
all children. The presence of one (viral) respiratory
pathogen may predispose to a second or third
(bacterial) infection [39,42,46]. The proportion of
mixed infections reported in other studies shows
large variations (10–74%) [9,33,34,38,39,46]. There
is a signiﬁcant seasonal inﬂuence on disease, so the
observation period of the present study was
2 years. In the second year, a low incidence
of prolonged coughing was observed, with few
Table 4. Number (%) of patients
with coughing and other symptoms
No
pathogen
One
pathogen
More than
one pathogen
Bordetella
pertussis Rhinovirus
Respiratory
syncytial virus
All (n = 135)a 45 (33) 49 (36) 41 (31)a 23 (17) 43 (32) 15 (11)
Coughing
Morning (n = 82) 25 (30) 26 (32) 31 (38) 16 (20) 30 (37) 11 (13)
Afternoon (n = 70) 22 (31) 21 (30) 27 (39) 17 (24) 26 (37) 9 (13)
Evening (n = 88) 25 (28) 32 (36) 31 (35) 20 (23) 31 (35) 9 (10)
Night (n = 89) 25 (28) 32 (36) 32 (36) 17 (19) 29 (33) 13 (15)
Symptoms
Fever (n = 47) 18 (38) 14 (30) 15 (32) 1 (2) 13 (28) 7 (15)
Tachypnoea (n = 51) 16 (31) 20 (39) 15 (29) 6 (12) 15 (29) 9 (18)
Dyspnoea (n = 63) 22 (35) 21 (33) 20 (32) 9 (14) 14 (22) 7 (11)
There were no signiﬁcant differences, except that there was less fever associated with Bordetella pertussis infection.
aData missing for one patient.
Versteegh et al. Community-acquired coughing in children 805
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 801–807
referrals, perhaps associated with the mild winter
of 2002–2003 and the warm summer of 2003 in The
Netherlands. However, the frequency of isolation
of two or more pathogens during both years of the
study in every season remained the same. Previous
studies have associated mixed infections with
more severe disease [3–6,43,44,48], but this was
not the case in the present study (Table 1). Gener-
ally, it seemed that there was one dominant
pathogen, with no cumulative or synergic effect
of a second pathogen. Patients with more than one
pathogen were signiﬁcantly older than those with
one or no pathogens, which might indicate that
they were more seriously ill than children of
similar age with one or no detectable pathogen.
This is supported by the fact that there was a slight
tendency for coughing to be more frequent in
patients with two or more pathogens (Table 4).
In summary, one pathogen was detected in 36%
of children with prolonged coughing, and more
than one pathogen in 31%. There was a strong
seasonal inﬂuence on the number of cases, but not
on the pathogens found or on the percentage of
multiple infections. Clinical data did not distin-
guish between pathogens, or whether or not
pathogens were found. There was no increase in
disease severity, with respect to symptoms and
hospitalisation, for cases of mixed or consecutive
infection, although this group was signiﬁcantly
older, suggesting that they had a more severe
disease than their peer groups with one or no
pathogens. Obviously, not all possible pathogens
found will cause illness, although it is still not
clear whether or how the presence of a colonising
potential respiratory pathogen inﬂuences or faci-
litates infection caused by other possible patho-
gens. It is therefore important to extend studies on
respiratory tract infections associated with more
than one pathogen in order to evaluate their
inﬂuence on disease severity.
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